Cassava Sciences, Inc. (NASDAQ: SAVA), is a biotechnology company focused on developing novel, investigational treatments, including simufilam, for central nervous system disorders, such as tuberous ...
This new laboratory workflow aims to combine both companies’ technologies to deliver AI-ready automation that can scale with expanding lab ecosystems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results